EFFECTIVENESS OF NEOADJUVANT TREATMENT IN LOCALLY ADVANCED BREAST CANCER (submitted in 2019)
6ER-002
A COMPARATIVE REVIEW OF THE IMPACT OF THE INTRODUCTION OF ON-SITE MOLECULAR TESTING ON THE MANAGEMENT OF ADULT PATIENTS HOSPITALISED WITH SUSPECTED INFLUENZA VIRUS INFECTION (submitted in 2019)
6ER-001
PCSK9 INHIBITORS: VARIATION IN THE LIPID PROFILE IN A REAL WORLD SETTING (submitted in 2019)
6ER-028
PERCEPTION OF HOSPITAL PHARMACISTS TOWARDS PHARMACOGENETIC TESTING
6ER-027
ABSTRACT WITHDRAWN
6ER-026
PERCEPTION OF A PEER-TO-PEER MENTORING EXPERIENCE WITH EUROPEAN PHARMACY STUDENTS IN A STUDENT-RUN FREE CLINIC
6ER-025
IMPACT OF THE NEW EUROPEAN REGULATION ON CLINICAL TRIALS IN THE ACTIVITY AND DYNAMICS OF RESEARCH ETHICS COMMITTEES FROM CATALONIA
6ER-024
ASPIRIN COMPARED TO ENOXAPARIN OR RIVAROXABAN FOR THE PREVENTION OF VTE FOLLOWING HIP AND KNEE REPLACEMENT – A RETROSPECTIVE COHORT STUDY IN IRELAND
6ER-023
ESTABLISHMENT OF GROUP WORK: WHAT IS THE EFFECT ON THE STATE OF KNOWLEDGE AND PERCEPTION OF PHARMACOVIGILANCE AMONG OUR FUTURE MOROCCAN PHARMACISTS?
6ER-022
WHAT IS PHARMACOVIGILANCE FOR YOU? A SURVEY OF 153 PHARMACISTS
6ER-021
WHY SUCH A LOW PARTICIPATION OF PHARMACISTS IN THE PATIENT EDUCATION PROGRAMMS IN OUR HOSPITAL?
6ER-020
SOCIAL AUTHORITIES CONCERNING #HOSPITALPHARMACY ON TWITTER
6ER-019
INTRODUCING YOUNG HOSPITAL PHARMACISTS TO SCIENTIFIC RESEARCH: AN EDUCATIONAL PROJECT SUPPORTED BY A NATIONAL SOCIETY FOR CLINICAL PHARMACY
6ER-018
DEVELOPMENT AND PERFORMANCE EVALUATION OF THE MEDICINES OPTIMISATION ASSESSMENT TOO: A PROGNOSTIC MODEL TO TARGET HOSPITAL PHARMACISTS' INPUT TO PREVENT MEDICATION-RELATED PROBLEMS
